Evaluation of Dosing and Clinical Outcomes in Patients Undergoing Conversion of Insulin Glargine to Insulin Detemir

Pharmacotherapy- United States

doi 10.1002/phar.1168

Full Text

Abstract

Available in

Date

January 1, 2013

Authors

Publisher

Wiley

Related search

Pharmacological and Clinical Profiles of New Soluble Basal Insulin Analogue, Insulin Detemir (Levemir®)

Folia Pharmacologica Japonica

Pharmacology

2008

English

Type III Allergy to Insulin Detemir

English

Systematic Review and Economic Evaluation of a Long-Acting Insulin Analogue, Insulin Glargine

Health Technology Assessment

Medicine

Health Policy

2004

English

Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials

English

Real World Outcomes of Adding Rapid-Acting Insulin Versus Switching to Analog Premix Insulin Among US Patients With Type 2 Diabetes Treated With Insulin Glargine

Patient Preference and Adherence

English

Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine

Diabetes, Obesity and Metabolism

English

Intensive Insulin Titration With Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients in Turkey: LANTIT Study

Turkish Journal of Endocrinology and Metabolism

English

Evaluation of Insulin and C-Peptide in Diabetic Patients Undergoing Renal Dialysis

International Journal of Research in Medical Sciences

2016

English

Pdb11 - Chart Review Analysis of Insulin Glargine 300 and Insulin Glargine 100 Use in France, Spain, and Germany

English

Amanote Research

Evaluation of Dosing and Clinical Outcomes in Patients Undergoing Conversion of Insulin Glargine to Insulin Detemir

Pharmacotherapy- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Pharmacological and Clinical Profiles of New Soluble Basal Insulin Analogue, Insulin Detemir (Levemir®)

Type III Allergy to Insulin Detemir

Systematic Review and Economic Evaluation of a Long-Acting Insulin Analogue, Insulin Glargine

Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials

Real World Outcomes of Adding Rapid-Acting Insulin Versus Switching to Analog Premix Insulin Among US Patients With Type 2 Diabetes Treated With Insulin Glargine

Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine

Intensive Insulin Titration With Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients in Turkey: LANTIT Study

Evaluation of Insulin and C-Peptide in Diabetic Patients Undergoing Renal Dialysis

Pdb11 - Chart Review Analysis of Insulin Glargine 300 and Insulin Glargine 100 Use in France, Spain, and Germany